KZRのニュース
Kezar Life Sciences, Inc. (NASDAQ:KZR) Sees Large Growth in Short Interest 2023/04/03 06:42:42 The AM Reporter
Kezar Life Sciences, Inc. (NASDAQ:KZR – Get Rating) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 4,890,000 shares, a growth of 13.2% from the February 28th total of 4,320,000 shares. Based on an average daily volume of 714,700 shares, […]
Kezar Life Sciences GAAP EPS of -$0.25 beats by $0.03 2023/03/14 20:52:35 Seeking Alpha
Kezar Life Sciences press release (KZR): Q4 GAAP EPS of -$0.25 beats by $0.03.Cash, cash equivalents and marketable securities totaled $276.6 million as of December 31, 2022
Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update 2023/03/14 20:01:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune mediated and oncologic disorders, today reported financial results for the fourth quarter and year ended December 31, 2022 and provided a business update. “We made tremendous progress in both of our first-in-class programs during 2022,” said John Fowler, Kezar’s Co-founder and Chief Executive Officer. “These s
Kezar Life Sciences Inc. (KZR) is an excellent investment, but the stock is overvalued/undervalued right now 2023/03/08 13:40:00 US Post News
In Tuesday’s session, Kezar Life Sciences Inc. (NASDAQ:KZR) marked $5.74 per share, down from $5.75 in the previous session. While Kezar Life Sciences Inc. has underperformed by -0.17%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KZR fell by -56.84%, with highs and lows ranging from […]
SYRS, ESPR and IBRX are among after hour movers 2023/03/01 23:02:46 Seeking Alpha
Gainers: Okta (OKTA) +13%. Kezar Life Sciences (KZR) +7%
Kezar Life Sciences: Mid-Term Growth Levers Heavily Discounted, Hold (KZR) 2022/11/16 06:23:57 Seeking Alpha
The market has heavily discounted Kezar Life Sciences'' growth catalysts of clinical trial updates and regulatory tailwinds. Read why I''ve narrowed my rating for KZR from Buy to Hold.
Why Kezar Life Sciences Inc. (NASDAQ: KZR) Stock Shouldn’t Be Ignored In 2022 2022/11/15 13:30:00 Marketing Sentinel
In the last trading session, 1.07 million shares of the Kezar Life Sciences Inc. (NASDAQ:KZR) were traded, and its beta was 0.18. Most recently the company’s share price was $7.97, and it changed around $0.35 or 4.59% from the last close, which brings the market valuation of the company to $517.01M. KZR currently trades at … Why Kezar Life Sciences Inc. (NASDAQ: KZR) Stock Shouldn’t Be Ignored In 2022 Read More »
Kezar Life Sciences Inc.’s (NASDAQ:KZR) Stock Price Plummets -56.76% This Year: A Look At Likely Future Paths 2022/11/11 16:00:00 Stocks Register
Kezar Life Sciences Inc. (NASDAQ:KZR) price on Thursday, November 10, rose 13.15% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $7.23. A look at the stock’s price movement, the close in the last trading session was $6.39, moving within a range at $6.65 and $7.2825. The beta … Kezar Life Sciences Inc.’s (NASDAQ:KZR) Stock Price Plummets -56.76% This Year: A Look At Likely Future Paths Read More »
Investing in Kezar Life Sciences Inc. (KZR) might be an excellent idea, but the stock is currently overvalued/undervalued 2022/11/11 12:16:00 US Post News
Kezar Life Sciences Inc. (NASDAQ:KZR) marked $7.23 per share on Thursday, up from a previous closing price of $6.39. While Kezar Life Sciences Inc. has overperformed by 13.15%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KZR fell by -2.82%, with highs and lows ranging from […]
Kezar Life Sciences, Inc. Tops Q3 EPS by 5c By Investing.com 2022/11/10 22:29:01 Investing.com
Kezar Life Sciences, Inc. Tops Q3 EPS by 5c
New Outlook On Kezar Life Sciences Inc. 2022/09/10 17:00:00 Stocks Register
Kezar Life Sciences Inc. (NASDAQ:KZR) price on Friday, September 09, rose 2.19% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $9.79. A look at the stock’s price movement, the close in the last trading session was $9.58, moving within a range at $9.65 and $10.055. The beta … New Outlook On Kezar Life Sciences Inc. Read More »
Was anything negative for Kezar Life Sciences Inc. (KZR) stock last session? 2022/09/09 11:40:00 US Post News
The share price of Kezar Life Sciences Inc. (NASDAQ:KZR) fell to $9.58 per share on Thursday from $9.67. While Kezar Life Sciences Inc. has underperformed by -0.93%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KZR rose by 22.82%, with highs and lows ranging from $18.55 […]
Do investors need to be concerned about Kezar Life Sciences Inc. (KZR)? 2022/09/01 13:48:00 US Post News
Kezar Life Sciences Inc. (NASDAQ:KZR) closed Wednesday at $10.28 per share, up from $9.84 a day earlier. While Kezar Life Sciences Inc. has overperformed by 4.47%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KZR rose by 34.91%, with highs and lows ranging from $18.55 to […]
Kezar Life Sciences to Participate in Three Upcoming Investor Conferences 2022/09/01 11:00:00 Wallstreet:Online
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that Christopher Kirk, PhD, Co-founder, President and Chief Scientific Officer, will participate in three upcoming investor conferences in September. Presentation Details: Event: 2022 Wells Fargo Healthcare
Is It Safe To Invest In Kezar Life Sciences Inc. (NASDAQ: KZR) Now? 2022/08/20 16:00:00 Stocks Register
Kezar Life Sciences Inc. (NASDAQ:KZR) price on Friday, August 19, rose 1.81% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $10.13. A look at the stock’s price movement, the close in the last trading session was $9.95, moving within a range at $9.7949 and $10.15. The beta … Is It Safe To Invest In Kezar Life Sciences Inc. (NASDAQ: KZR) Now? Read More »